Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-07-30 2019-07-29
Drug Identification Number 02470780 02470780
Brand name APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Common or Proper name LANSOPRAZOLE LANSOPRAZOLE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE
Strength(s) 500MG 500MG 30MG 500MG 500MG 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET
Route of administration ORAL ORAL
Packaging size 56 BLS 56 BLS
ATC code A02BD A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-02 2019-07-02
Estimated end date 2019-07-28 2019-07-28
Actual end date 2019-07-29 2019-07-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments